Navigation Links
ALIMTA Helped Keep Most Common Form of Lung Cancer at Bay In Elderly Patients
Date:9/26/2011

sup>a clinical trial investigator for the PARAMOUNT study and physician with S. Giuseppe Moscati Hospital in Avellino, Italy. "In fact, some patients over the age of 70 may simply be offered supportive care alone. These results show that an ALIMTA maintenance regimen could provide benefit to certain elderly patients."

The study included patients with advanced nonsquamous NSCLC who received ALIMTA (500 mg/m2 on day one of a 21-day cycle) in combination with cisplatin (75 mg/m2) induction therapy. Patients whose disease had not progressed during the ALIMTA plus cisplatin induction and had a performance status of 0-1 were randomized to receive ALIMTA maintenance (500 mg/m2 on day one of a 21-day cycle) plus best supportive care or placebo plus best supportive care until disease progression.

Overall, the most serious (laboratory grade 3/4) drug-related adverse events were higher for elderly patients treated with ALIMTA continuation maintenance compared with patients less than 70 years of age (21% vs. 7%). These adverse events were primarily hematological (anemia and neutropenia). Elderly patients in the study tended to have a poorer performance status than younger patients (PS 0: 20% vs. 34%, respectively; PS 1: 79% vs. 66%, respectively), and the older group received more cycles of ALIMTA therapy (5.5 vs. 4.8 in the younger group).

Overall results of PARAMOUNT, which met its primary endpoint of progression-free survival, were presented in June 2011 at the American Society of Clinical Oncology (ASCO) Annual Meeting(1).

Notes to Editor

About Non-Small Cell Lung Cancer (NSCLC)

Globally, lung cancer is the most common form of cancer and the biggest killer, causing 1.3 million cancer deaths annually(2).  About 85 – 90 percent of all lung cancers are NSCLC(3).  The liver, bones and brain are potential targets if the cancerous cells enter the bloodstream.

NSCLC comprises a group of histolo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
2. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
3. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
4. Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
5. ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
6. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
7. Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax
8. UT Southwestern Doctors Expertise Helped Trapped Chilean Miners During Pressured Half-Mile-Deep Rescue
9. Cintas ReviveR AEDs Helped Save Over 50 Lives at LA Fitness Facilities
10. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
11. Genetics Determine Optimal Drug Dose of Common Anticoagulant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 /CNW/ - Today, the Honourable Rona Ambrose, ... animal health organizations to discuss the Government of ... (AMR). The roundtable provided an important ... share their priorities and discuss roles and responsibilities in ... their optimal use (also known as antimicrobial stewardship) was ...
(Date:3/31/2015)... 2015 Point-of-Care Partners, a leading health ... has launched the ePA State Navigator -- a ... payers and pharmacies to quickly assess the evolving ... of prescription medications. Today, the majority ... through time-consuming, manual processes amongst prescribers, health plans ...
(Date:3/31/2015)... Mar. 27, 2015 Research and Markets ... "Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative ... report to their offering. The global intraoperative ... of 3.5% from 2014 to 2019 It ... a number of forces that favor this market. The ...
Breaking Medicine Technology:Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 2Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 3Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 4Point-of-Care Partners Launches the ePA State Navigator 2Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2
...  Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today ... by prescription nationwide. This is the only fluoxetine ... The U.S. Food and Drug Administration (FDA) approved ... tablets in October 2011. (Photo: ...
... Brand™ announces the release of VB ... for expanding serialization and traceability regulations for pharmaceutical, biologics, medical ... E nterprise 4.0 for Life Sciences adds support for ... interface standard. Verify Brand™ has also gone beyond ...
Cached Medicine Technology:Edgemont - New Fluoxetine Tablets, 60 mg Now Available 2Edgemont - New Fluoxetine Tablets, 60 mg Now Available 3Edgemont - New Fluoxetine Tablets, 60 mg Now Available 4Edgemont - New Fluoxetine Tablets, 60 mg Now Available 5Edgemont - New Fluoxetine Tablets, 60 mg Now Available 6Verify Brand™ Announces the Release of VB Enterprise 4.0 for Life Sciences 2Verify Brand™ Announces the Release of VB Enterprise 4.0 for Life Sciences 3
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 San ... and the international children’s medical charity, Operation Smile, ... new global partnership. , Campaign Details: RxOrganics is ... Rxmedical line to Operation Smile throughout 2015. RxOrganics ... on such sales so that every order placed online ...
(Date:4/1/2015)... TCS Healthcare Technologies (TCS), a leading ... management and population health arenas, is pleased to announce ... which is fully integrated with the ACUITY platform. , ... p.m. ET, will be led by Jeff Frater, RN, ... explore the feature-rich portal as well as the importance ...
(Date:4/1/2015)... 2015 Nike Golf Camps has expanded ... Arizona and Florida. These programs are specifically designed for ... in a golf-intensive environment and to learn about the ... of Arizona coaching legend, Rick LaRose, spends significant time ... gaps as it pertains to the recruiting and college ...
(Date:4/1/2015)... Oak Brook, IL (PRWEB) April 01, 2015 ... unfortunately benefited greatly from climate change in recent years, ... will develop an allergic reaction if exposed to poison ... as outdoor enthusiasts and families prepare for summer adventures ... of an uncomfortable poison plant reaction is greater than ...
(Date:3/31/2015)... 31, 2015 Due to its ... hire more caregivers, staffing personnel, and marketing managers, ... managers within the Greater Los Angeles area. In ... 1Heart Caregiver University has firmed up its training ... to provide quality in-home care through a client-centered ...
Breaking Medicine News(10 mins):Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:TCS Healthcare Technologies Releases Acuity Connect 2Health News:TCS Healthcare Technologies Releases Acuity Connect 3Health News:US Sports Camps and Nike Golf Camps to Host Golf Development Camps in Arizona and Florida 2Health News:US Sports Camps and Nike Golf Camps to Host Golf Development Camps in Arizona and Florida 3Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3
... veterans face some unique health issuesMINNEAPOLIS/ST. PAUL, Minn., May ... to school this fall as a result of the ... ensure student veterans, unique needs are met, according to ... the University of Minnesota and Minnesota State ...
... Angeles, London, New Delhi, Singapore and Washington DC (May 29, 2009) ... an over-the-counter, rapid HIV test for home use, according to a ... MDM ) which is published by SAGE. , As ... are at greater risk for HIV infection will not be able ...
... DALLAS, May 29 BeaconEquity.com announces availability of alerts on ... trading. The alerts include recent news, trading activity and technical ... stock alerts for free by visiting ... Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI ), Peregrine Pharmaceuticals ...
... disease, risks may outweigh benefits, research suggests , , ... attack risk in people with no previous history of ... say British researchers who analyzed the results of 22 ... this group of patients is uncertain because the benefits ...
... & Lomb,s Expanding Ocular Pharmaceuticals Portfolio and Offers New ... Pathogens(1) - , MADISON, N.J., May 29 Bausch ... announced that the U.S. Food and Drug Administration (FDA) ... the treatment of bacterial conjunctivitis, commonly referred to as ...
... at Digestive Disease Week, addressing the topic of invention of new ... ... May 29, 2009 -- Zeus, Inc., a leader in polymer extrusions ... Digestive Disease Week in Chicago on June 1, 2009. Zeus ...
Cached Medicine News:Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3Health News:FDA ignores critical information on home HIV tests 2Health News:Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants 2Health News:Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants 3Health News:Value of Taking Aspirin to Cut Heart Risk Varies 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 3Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 4Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 5Health News:Zeus to Present at Digestive Disease Week in Chicago 2
Thermal Seal, Clear, Bulk...
Acetate Plate Sealers 100/Box...
... seals provide an adhesive-based sealing option for ... adhesive layer ensures secure sample storage or ... sealing during thermal cycling when supplemental pressure ... perforated end-tabs can be removed when using ...
TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape....
Medicine Products: